These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18945373)

  • 1. Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003.
    Hsieh SC; Lin IH; Tseng WL; Lee CH; Wang JD
    Chin Med; 2008 Oct; 3():13. PubMed ID: 18945373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription patterns of Chinese herbal products for patients with sleep disorder and major depressive disorder in Taiwan.
    Chen YL; Lee CY; Huang KH; Kuan YH; Chen M
    J Ethnopharmacol; 2015 Aug; 171():307-16. PubMed ID: 26068429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database.
    Hsieh SC; Lai JN; Lee CF; Hu FC; Tseng WL; Wang JD
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):609-19. PubMed ID: 18481335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription pattern of Chinese herbal products for heart failure in Taiwan: A population-based study.
    Tsai MY; Hu WL; Lin CC; Lee YC; Chen SY; Hung YC; Chen YH
    Int J Cardiol; 2017 Feb; 228():90-96. PubMed ID: 27863367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and co-prescription pattern of Chinese herbal products for hypertension in Taiwan: a Cohort study.
    Yang PR; Shih WT; Chu YH; Chen PC; Wu CY
    BMC Complement Altern Med; 2015 Jun; 15():163. PubMed ID: 26048045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of traditional Chinese medicine in patients with hyperlipidemia: A population-based study in Taiwan.
    Chu SM; Shih WT; Yang YH; Chen PC; Chu YH
    J Ethnopharmacol; 2015 Jun; 168():129-35. PubMed ID: 25828254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Chinese Herbal Medicine in the Treatment of Chronic Obstructive Pulmonary Disease (COPD).
    Liao YN; Hu WL; Chen HJ; Hung YC
    Am J Chin Med; 2017; 45(2):225-238. PubMed ID: 28231744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription profile of Chinese herbal products containing coumestrol, genestein, and/or daidzein among female users: an analysis of national health insurance data in Taiwan between 1997 and 2007.
    Wu CT; Tzeng JN; Lai JN; Tsan SH; Wang JD
    Chin Med; 2012 Oct; 7(1):22. PubMed ID: 23072740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese Herbal Products for Ischemic Stroke.
    Hung IL; Hung YC; Wang LY; Hsu SF; Chen HJ; Tseng YJ; Kuo CE; Hu WL; Li TC
    Am J Chin Med; 2015; 43(7):1365-79. PubMed ID: 26477801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of liver injury associated with Chinese herbal products containing radix bupleuri in 639,779 patients with hepatitis B virus infection.
    Lee CH; Wang JD; Chen PC
    PLoS One; 2011 Jan; 6(1):e16064. PubMed ID: 21264326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequencies and prescription patterns of traditional Chinese medicine use among elderly patients in Taiwan: A population-based study.
    Yang PR; Liang HF; Chu YH; Chen PC; Lin YY
    J Ethnopharmacol; 2015 Jul; 169():328-34. PubMed ID: 25952167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular identification and cytotoxicity study of herbal medicinal materials that are confused by Aristolochia herbs.
    Li M; Au KY; Lam H; Cheng L; But PP; Shaw PC
    Food Chem; 2014 Mar; 147():332-9. PubMed ID: 24206727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription patterns of Chinese herbal products for patients with fractures in Taiwan: A nationwide population-based study.
    Liao HH; Yeh CC; Lin CC; Chen BC; Yeh MH; Chang KM; Sun MF; Yen HR
    J Ethnopharmacol; 2015 Sep; 173():11-9. PubMed ID: 26187277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription pattern of Chinese herbal products for adult-onset asthma in Taiwan: a population-based study.
    Wang HM; Lin SK; Yeh CH; Lai JN
    Ann Allergy Asthma Immunol; 2014 May; 112(5):465-70. PubMed ID: 24656660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription pattern of chinese herbal products for breast cancer in taiwan: a population-based study.
    Lai JN; Wu CT; Wang JD
    Evid Based Complement Alternat Med; 2012; 2012():891893. PubMed ID: 22685488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese Herbal Products for Non-Motor Symptoms of Parkinson's Disease in Taiwan: A Population-Based Study.
    Lin CH; Chiu HE; Wu SY; Tseng ST; Wu TC; Hung YC; Hsu CY; Chen HJ; Hsu SF; Kuo CE; Hu WL
    Front Pharmacol; 2020; 11():615657. PubMed ID: 33584294
    [No Abstract]   [Full Text] [Related]  

  • 17. Prescription patterns of chinese herbal products for osteoporosis in taiwan: a population-based study.
    Shih WT; Yang YH; Chen PC
    Evid Based Complement Alternat Med; 2012; 2012():752837. PubMed ID: 23093986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An easy and rapid method to determine aristolochic acids I and II with high sensitivity.
    Sun Z; Liu L; Zheng X; Fan C; Wang Q; Li G
    Anal Bioanal Chem; 2004 Jan; 378(2):388-90. PubMed ID: 13680054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing and targeted quantitative real-time polymerase chain reaction for detection of
    Song Y; Yang Z; Wang P; Song K; Zhang S; Fan T
    Ann Transl Med; 2022 Jun; 10(12):706. PubMed ID: 35845488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 8 years post-marketing surveillance between Asari Radix and hepatocellular carcinoma: Nationwide population-based evidence against an association.
    Chen CN; Tsai YT; Lai JN
    J Ethnopharmacol; 2019 Oct; 243():112094. PubMed ID: 31323301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.